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Secreted Wnt morphogens are signaling molecules
essential for embryogenesis, pathogenesis, and
regeneration and require distinct modifications for
secretion, gradient formation, and activity. Whether
Wnt proteins can be posttranslationally inactivated
during development and homeostasis is unknown.
Here we identify, through functional cDNA screening,
a transmembrane protein Tiki1 that is expressed
specifically in the dorsal Spemann-Mangold Orga-
nizer and is required for anterior development during
Xenopus embryogenesis. Tiki1 antagonizes Wnt
function in embryos and human cells via a TIKI
homology domain that is conserved from bacteria
to mammals and acts likely as a protease to cleave
eight amino-terminal residues of a Wnt protein, re-
sulting in oxidized Wnt oligomers that exhibit normal
secretion but minimized receptor-binding capability.
Our findings identify a Wnt-specific protease that
controls head formation, reveal a mechanism for
morphogen inactivation through proteolysis-induced
oxidation-oligomerization, and suggest a role of
the Wnt amino terminus in evasion of oxidizing
inactivation. TIKI proteins may represent potential
therapeutic targets.INTRODUCTION
The Wnt family of secreted proteins control embryogenesis,
homeostasis, and regeneration, and Wnt signaling deregulationcauses birth defects, cancer, osteoporosis, and other diseases
(Clevers, 2006; Logan and Nusse, 2004; MacDonald et al.,
2009; Moon et al., 2004). As prototypic morphogens, Wnt
proteins exhibit short- and long-range signaling properties in
a concentration gradient field (Hausmann et al., 2007; Strigini
and Cohen, 2000; Zecca et al., 1996). Mechanisms that regulate
Wnt biogenesis and gradient formation have not been fully
defined. Critical for Wnt biogenesis/function are posttransla-
tional modifications including N-glycosylation and lipidation, as
best exemplified for mouse Wnt3a. O-acylation of serine 209
(S209) and N-glycosylation appear to be required for Wnt3a
secretion (Komekado et al., 2007; Takada et al., 2006), whereas
palmitoylation of cysteine 77 (C77) is suggested to be important
for Wnt3a activity (Willert et al., 2003). These modifications
have profound influence on Wnt exocytic trafficking, extracel-
lular distribution, and/or receptor binding (Cong et al., 2004;
Franch-Marro et al., 2008; Komekado et al., 2007; Kurayoshi
et al., 2007; Takada et al., 2006; Willert et al., 2003; Zhai et al.,
2004). Whether Wnt proteins are posttranslationally modified
and inactivated is unknown.
Canonical Wnt signaling plays a central role in anterior-poste-
rior (AP) patterning (De Robertis and Kuroda, 2004; Niehrs, 2004;
Petersen and Reddien, 2009). Wnt engagement of receptors
including the Frizzled (Fz) serpentine receptor and the single-
span LDL receptor-related protein 6 (LRP6) induces the stabili-
zation of transcription coactivator b-catenin (He et al., 2004;
MacDonald et al., 2009), thereby activating gene expression
for AP patterning. In Xenopus embryos, an AP gradient of Wnt
signaling occurs with the highest level posteriorly, and the dorsal
Spemann-Mangold Organizer promotes head development
via secreting Wnt antagonists such as secreted Fz-related
proteins (sFRPs) and Dickkopf-1 (Dkk1), which bind to and
inhibit Wnt/Fz or LRP6 to keep Wnt signaling low anteriorly
(De Robertis and Kuroda, 2004; Harland and Gerhart, 1997;Cell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc. 1565
Figure 1. Tiki1 Promotes Anterior Development and Inhibits Wnt
Signaling
(A) Dorsal injection of Tiki1 mRNA (100 pg) induced enlarged head similar to
that induced by Dkk1.
(B) Tiki1 domain scheme. SP, signal peptide; TM, transmembrane.
(C) Phylogenetic tree of Tiki proteins from human, Xenopus, zebrafish, Nem-
atostella, C. elegans, and Amphimedon by ClustalW (see Figure S1). TIKI
domain is homologous to bacterial gumN (see Figure S2A).
(D) Tiki1 inhibited Xwnt8-induced Xnr3 expression in animal caps. EF-1a:
a loading control; uninj: uninjected embryos; WE: whole embryos.
(E) Tiki1 inhibited axis duplication by Xwnt8 but not by LRP6DN, Xdsh, or
b-catenin. LDLR: a control. Numbers indicate embryos scored.
(F and G) Tiki1 did not inhibit Nodal or FGF signaling.
See also Figures S1 and S2.Niehrs, 2004). Here we describe an Organizer-specific trans-
membrane protein, Tiki1, which is required for head formation
via cleavage and inactivation of Wnt ligands.
RESULTS
Expression Cloning of Tiki1
We performed a functional cDNA expression screen in Xenopus
embryos to identify genes involved in AP patterning/Wnt
signaling. One isolated cDNA caused head enlargement
and was named Tiki1 (Tiki refers to a large-headed humanoid
in Polynesian mythology) (Figure 1A). Tiki1 encodes a type I
transmembrane protein of 508 residues with an amino-terminal1566 Cell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc.signal peptide, an ectodomain, and a transmembrane domain
at the carboxyl terminus (Figure 1B). Tiki1 is the founding
member of a conserved protein family, and a Tiki1 homolog is
encoded in the genome of sponge Amphimedon queenslandica
and sea anemone Nematostella vectensis and is likely in
the common ancestor before invertebrates and vertebrates
diverged (Figure 1C and Figure S1 available online). Most verte-
brates including Xenopus, zebrafish, and human have two
genes, Tiki1 and Tiki2 (Figures 1C and S1). Tiki proteins do not
harbor known motifs but exhibit a conserved 340-residue
ectodomain, referred to as the TIKI domain, which shares 25%
identity/40% similarity with putative bacterial gumN proteins of
unknown functions (Figures 1C and S2A).
Tiki1 Antagonizes Wnt Function
Head enlargement by Tiki1 overexpression phenocopies that
by Dkk1 (Figure 1A), a Wnt/LRP6 antagonist (He et al., 2004).
Indeed, Tiki1 antagonized Wnt function and inhibited axis dupli-
cation and induction of Xnr3 (a Wnt target gene) by Xenopus
wnt8 (Xwnt8) but not by b-catenin or Dishevelled, another Wnt
downstream component, and importantly not by a constitutively
active LRP6DN (Tamai et al., 2004) (Figures 1D and 1E). Thus
Tiki1 likely acts at or upstream of Wnt receptors. Tiki1 did not
affect signaling by secreted factors such as Nodal, a transform-
ing growth factor-b (TGF-b) protein, or basic fibroblast growth
factor (bFGF) (Figures 1F and 1G), attesting to its specificity.
Xenopus Tiki2 and human TIKI1 and TIKI2 also behaved as
Wnt antagonists in embryos (not shown), HEK293T cells (Fig-
ure S2B), and mouse L cells (below). TIKI1N or TIKI2N, which
is a secreted form of the respective ectodomain (Figures 1B
and S1), was fully functional and interchangeable with TIKI1/2
in embryos (not shown) and cultured cells (Figure S2C).
Organizer Expression of Tiki1
RT-PCR revealed that Tiki1 messenger RNA (mRNA) becomes
detectable at stage 9 and is prominently expressed from stage
10 (early gastrula) to stage 30 (tadpole) (Figure 2A) and interest-
ingly is restricted to the dorsal segment of the gastrula (Fig-
ure 2B). At stage 10, Tiki1 is expressed exclusively in the dorsal
blastopore lip, the Organizer, in a pattern similar to that of Dkk1
(Figures 2C and 2D). Longitudinal hemisectioning of the stage
10.5 embryo revealed that Tiki1 is excluded from the dorsal
margin of the Organizer and overlapped with Dkk1 expression
in the prechordal mesoderm and endomesoderm (Figures 2E
and 2F). At stage 11, Tiki1 andDkk1 are expressed in the anterior
prechordal plate (Figures 2G and 2H). By blastopore closure,
Tiki1 expression becomes distinct from that of Dkk1, as Tiki1 is
restricted to the anterior midline, whereas Dkk1 displays
a wing-shaped expression straddling Tiki1 (Figures 2I and 2J).
At early neurula, Tiki1 is expressed in the midline anterior to
the tip of the notochord in cells of the endoderm and overlying
neural ectoderm, whereas Dkk1 has a more broad expression
pattern in the prospective ventral forebrain (Figures 2K and 2L).
Thus Tiki1 is zygotically expressed in the Organizer, in particular
in the head organizer region responsible for anterior patterning.
Organizer formation requires maternal Wnt signaling (De Rob-
ertis and Kuroda, 2004; Harland and Gerhart, 1997). Ectopic
Xwnt8 induced Tiki1 and Dkk1 expression ventrally, whereas
Figure 2. Tiki1 Expression and Regulation in Early
Embryos
(A) RT-PCR revealed that Tiki1 mRNA is detectable from
stages 9 to 30.
(B) Tiki1 is expressed dorsally. Embryos were cut into
animal, vegetal, dorsal, and ventral parts for RT-PCR.
Xnr3: a positive control.
(C–L) Whole-mount in situ hybridization of Tiki1 and Dkk1
during gastrulation. Drawing is on right. (C and D) Vegetal
view, dorsal on top; (E and F) hemisection, dorsal on right;
(G–L) dorsal view, anterior on top.
(M) Tiki1 expression depends on maternal Wnt signaling.
Con: control, UV: ultraviolet.a dominant-negative TCF (T cell factor, a DNA-binding factor
that mediates b-catenin signaling), DNTCF (Molenaar et al.,
1996), suppressed the endogenous Tiki1 and Dkk1 dorsal
expression (Figure 2M). LiCl, which stabilizes b-catenin and
thus dorsalizes embryos, induced Tiki1 and Dkk1 expression,
whereas ultraviolet irradiation, which causes defective maternal
Wnt signaling and ventralizes embryos, suppressed Tiki1 and
Dkk1 expression (Figure 2M). Thus maternal Wnt signaling is
necessary and sufficient for Tiki1 and Dkk1 expression in the
Organizer.
Tiki1 Is Required for Head Development
We performed Tiki1 protein depletion using a Tiki1 morpholino
antisense oligonucleotide (Tiki1MO), which specifically blocked
the synthesis of the exogenously expressed Tiki1 (Tiki1-FLAG)
in embryos (Figure 3A). Tiki1MO was unable to block the
synthesis of HA*Tiki1, whose mRNA was engineered to lack
the MO-targeting sequence, attesting to Tiki1MO specificity
(Figure 3A). We injected 20 ng of Tiki1MO into two dorsal
blastomeres of 8-cell stage embryos. Strikingly, roughly 50%
of Tiki1MO-injected embryos developed anterior defects and
exhibited loss of forebrain structures (including diminishment
or loss of the cement gland and eyes) or cyclopic eyes fused
at the midline (Figures 3B and 3C). HA*Tiki1 mRNA rescued
Tiki1MO phenotypes (Figures 3B and 3C). Supporting a role of
Tiki1 in Wnt inhibition during head formation, Dkk1 mRNA also
rescued Tiki1MO anterior deficiency phenotypes (Figure S3A).
Tiki1MO suppressed the expression of head organizer genes
including Goosecoid (Gsc), Lim1, Otx2, and Dkk1 in gastrula
embryos (stages 10.5–11) (Figure 3D and Table S1). Tiki1MO
also inhibited the expression of Organizer gene Chordin but
not of Organizer or dorsal genes Xnr3 and Xnot (Figure 3D and
Table S1), which are not involved in head organizer function.
Tiki1MO reduced Gsc expression in the prechordal plate, the
descendent of the head organizer, in neurula (Figure S3B and
Table S1). HA*Tiki1 mRNA rescued Tiki1MO effects on all headCell 149, 156organizer genes examined (Figure 3D and Table
S1). Control MO did not affect any marker
examined (Figure 3D and Table S1). Tiki1MO
did not affect Gsc expression prior to stage
10.5 (Figure S3C and Table S2), which relies
on maternal Wnt signaling (Cho et al., 1991;
Christian and Moon, 1993). Thus Tiki1 is re-quired for maintenance of the head organizer via antagonizing
zygotic Wnt signaling. Consistent with this, Tiki1 inhibited
Xwnt8 posterizing effect when both were expressed dorsally
and zygotically via injected plasmids (Figure S3D).
Tiki1 expression/function in the head organizer implies its role
in anterior-neural patterning. Tiki1MO injected into one dorsal-
animal blastomere at the 8-cell stage suppressed at stage 16
the expression of forebrain markers BF1 and Otx2 and the
midbrain marker En2, but not the posterior-neural marker
Hoxb9, and HA*Tiki1 mRNA rescued the expression of BF1,
Otx2, and En2 in Tiki1MO-injected embryos (Figure S3E
and Table S3). Therefore, Tiki1 is required for anterior-neural
patterning.
TIKI Expression and Function in Human Cells
Tiki genes exhibit specific expression during embryogenesis
(Figure 2 and data not shown). We found, unexpectedly, that
human HEK293T and HeLa cells, which are commonly used
for Wnt signaling studies, express mRNAs for TIKI2 and TIKI1
plus TIKI2, respectively (Figure 4A and data not shown).
Depletion of TIKI2 in HEK293T cells via small interfering
RNAs (siRNAs) enhanced Wnt3a-induced reporter expression
by up to 7-fold (Figure 4B), and the enhancement levels
correlated with the extent of reduction of TIKI2 mRNA
and the tagged TIKI2 protein by the siRNAs (Figures 4C and
S4A); furthermore, the TIKI2 siRNA effect was rescued by
ectopic TIKI1 expression (Figure 4D). Thus the endogenous
TIKI protein(s) acts to restrain Wnt signaling in cultured human
cells.
Wnt Inactivation by Tiki Proteins
We investigated how Tiki antagonizes Wnt signaling. Upon
expression in HEK293T or HeLa cells, Tiki1/TIKI1 and TIKI2
were detected at the plasma and internal membranes via
imaging and surface biotinylation (Figures 4E–4G). We stably
expressed TIKI2 in L cells or Wnt3a-expressing L cells (which5–1577, June 22, 2012 ª2012 Elsevier Inc. 1567
Figure 3. Tiki1 Is Required for Anterior Develop-
ment
(A) Tiki1MO (5, 10, 20, and 40 ng) inhibited protein
expression from Tiki1-FLAG but not HA*Tiki1 mRNAs
(500 pg).
(B) Tiki1MO (20 ng) caused anterior defects, which were
rescued by HA*Tiki1 mRNA (50 pg). Lateral (left) and
dorso-anterior (right) views are shown at stage 42.
(C) Statistical data of the Tiki1MO phenotype.
(D) Tiki1MO suppressed head organizer gene expression
at stages 10.5–11.
See also Figure S3 and Tables S1, S2, and S3.expressed TIKI1 poorly ectopically). TIKI2 inhibited b-catenin
stabilization in Wnt3a-producing cells (Figure 4H, lanes 5 and
6) but apparently not in cells treated with Wnt3a conditioned
media (CM) (Figure 4H, lanes 3 and 4). Interestingly Wnt3a
produced in L cells was secreted normally into CM in the
presence of TIKI2 but exhibited faster electrophoretic migration
prior to (in whole-cell lysates) and after secretion (in CM) (Fig-
ure 4I). Similar results were observed for Wnt3a in HEK293T
cells that coexpress TIKI1 or TIKI2 (Figure S4B). Wnt3a secreted
from TIKI-expressing cells exhibitedminimal activity, as it neither
induced theWnt-responsive reporter (Figure 4J) or phosphoryla-
tion of LRP6 and Dishevelled nor stabilized b-catenin (Figure 4K).
Revealingly, Wnt3a secreted from TIKI2-expressing cells bound
to neither Fz nor LRP6 (Figure 4L). Thus TIKI proteins result in
a Wnt3a modification that minimizes Wnt3a activity but not
secretion.
Elimination of Wnt Hydrophobicity by Tiki Proteins
Palmitoylation at C77 appears to be required for Wnt3a binding
to Fz and LRP6, and the inactivity of Tiki-modified Wnt3a is
reminiscent of Wnt3a(C77A), which harbors alanine substitution
of C77 and lacks palmitoylation (Cong et al., 2004; Komekado
et al., 2007; Willert et al., 2003). In a detergent-aqueous phase
separation assay, Wnt3a partitions in Triton X-114 detergent,
whereas Wnt3a(C77A) is soluble aqueously (Komekado et al.,
2007; Willert et al., 2003). Wnt3a from TIKI1/2-expressing
cells partitions exclusively in the aqueous phase (Figures 5A
and S4C), further resembling Wnt3a(C77A). Unexpectedly,
metabolic labeling detected little difference in Wnt3a palmitate1568 Cell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc.incorporation with or without TIKI2 (Figures
5B and S4D). Wnt3a(C77A), and in fact
Wnt3a(C77A/S209A) that harbors alanine
substitutions at both C77 and S209 and lacks
lipidation at these two residues, were modified
by TIKI2 as judged by electrophoretic mobility
changes (Figures S4E and S4F), and the
residual autocrine signaling activity of
Wnt3a(C77A) was inhibited by TIKI2 (Fig-
ure S4G). TIKI2 also modified Wnt3a(N87Q/
N298Q), which has glutamine substitutions at
the two glycosylated asparagines and lacks
N-glycosylation (Komekado et al., 2007) (Fig-
ure S4F). Thus despite elimination of Wnt3a
hydrophobicity, Tiki modification of Wnt3aappears to be unrelated to C77 or S209 acylation or N-
glycosylation.
Wnt Amino-Terminal Cleavage by Tiki Proteins
Wnt3a mutants deleted of the amino-terminal region were
invariably resistant to Tiki modification (Figure S4H). Edman
sequencing of TIKI2-modified Wnt3a revealed that eight
amino-terminal residues, SYPIWWSL, had been removed from
the mature Wnt3a (i.e., after signal peptide removal) (Figure 5C).
A quantitative mass spectrometry (MS) approach was taken to
further analyze this amino-terminal processing. Wnt3a was ex-
pressed alone or with TIKI2 in light or heavy stable isotope
labeling by amino acids in cell culture (SILAC) medium (Ong
et al., 2002) and analyzed for MS using FLEXIQuant quantifica-
tion (Singh et al., 2009, 2012) (Figure S5A). The relative peptide
peak ratios of Wnt3a with and without TIKI2 confirmed
cleavage of the eight residues in TIKI2-modified Wnt3a and
also uncovered two additional cleavage sites of lesser abun-
dance, which are seven and eight residues downstream of
the main cleavage site (Figures 5C, S5B, and S5C). The relative
peptide peak ratios for the remaining Wnt3a with or without
TIKI2 were largely unperturbed, suggesting that TIKI2 might
not affect the rest of the Wnt3a protein (Figure S5B and Table
S4). We generated HA-Wnt3a, which harbors the HA tag after
the signal peptide. Remarkably, TIKI1 and TIKI2 resulted in
removal of the HA epitope while leaving the rest of Wnt3a
apparently intact (Figure 5D). The HA tag had no influence on
Wnt3a cleavage by TIKI2 (Figure S6A). TIKI2 did not cleave
the HA tag in HA-R-spondin1 (Rspo1; Wei et al., 2007),
Figure 4. Tiki Inactivates Wnt3a
(A) Relative expression levels of TIKI1 and TIKI2 mRNAs in HEK293T cells.
(B) Knocking down endogenous TIKI2 in HEK293T cells enhanced Wnt3a signaling.
(C) TIKI2 mRNA knockdown examined 48 hr after siRNA transfection.
(D) The TIKI2 knockdown effect was countered by TIKI1 expression.
(E and F) Immunofluorescence of HA*Tiki1 expressed in HeLa cells. Live cells (E) or fixed-permeabilized cells (F) were labeled by an anti-HA antibody and
a fluorescent secondary antibody.
(G) HeLa cells expressing HA-TIKI1 or HA-TIKI2 were treated with a nonpermeable biotinylation reagent. Cell surface (CS) proteins were precipitated with
streptavidin beads and blotted for HA-TIKI1/2. WCL: input whole-cell lysates. The slower-migrating form of HA-TIKI, due possibly to glycosylation, was enriched
on the cell surface.
(H) TIKI2 inhibited b-catenin stabilization inWnt3a-expressing cells. Indicated L cell lines were also treated with control orWnt3a CM for 2 hr (lanes 1–4). b-tubulin:
a loading control.
(I) Wnt3a was secreted similarly with or without TIKI2 but exhibited faster migration due to TIKI2.
(J) Wnt3a CM from TIKI2-expressing L cells exhibited minimal activity, tested at concentrations in 2-fold dilutions.
(K)Wnt3a CM from TIKI2-expressing L cells inducedminimal LRP6 or Dvl2 phosphorylation or b-catenin stabilization at 2 hr. LRP6 intensity reduction was not due
to decreased protein levels but due to LRP6 phosphorylation, which perturbed recognition by the LRP6 antibody used (not shown).
(L) Wnt3a secreted from TIKI2-expressing cells exhibited minimal binding to mFz8CRD-IgG or LRP6N-IgG (Tamai et al., 2000).
All error bars represent standard deviation (SD) in triplicates. See also Figure S4.a secreted Wnt agonist that harbors the HA tag after the signal
peptide (Figure 5E). siRNA knockdown of the endogenous
TIKI2 reduced the cleavage of HA-Wnt3a in HEK293T cells,
as shown by increased retention of the HA epitope (Figure 5F).Thus Tiki resulted in amino-terminal cleavage of Wnt3a (but
not Rspo1), consistent with data from Edman sequencing
and SILAC-FLEXIQuant analysis. To confirm TIKI cleavage
specificity, we altered the two residues straddling the mainCell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc. 1569
Figure 5. Tiki Inactivates Wnt3a via Amino-Terminal Cleavage
(A) Triton X-114 phase separation. Control Wnt3a partitioned in detergent (De), but Wnt3a from TIKI2-expressing cells partitioned in aqueous (Aq) phase. T, total.
(B) TIKI2 did not affect Wnt3a acylation (C77 plus S209) in metabolic labeling.
1570 Cell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc.
and minor cleavage sites in Wnt3a (Figure 5C). These HA-
Wnt3a mutants, Wnt3a(S25D/L26D) and Wnt3a(S25D/L26D/
S33D/S34D), were partially and completely resistant to TIKI2
proteolysis, respectively (Figure 5G, lanes 2, 4, and 6), demon-
strating that TIKI2 acts through these residues. We then gener-
ated Wnt3aDN, which lacks the exact eight residues removed
by TIKI2 (Figure 5C). Wnt3aDN was secreted normally but
partitioned in the aqueous phase and exhibited minimal activity
(Figures 5H and 5I), thereby behaving like Tiki-modified Wnt3a
(Figure 4J). Therefore, Tiki promotes cleavage of the Wnt3a
amino terminus, which has an essential role in Wnt3a activity.
Supporting this notion, Wnt3a(S25D/L26D/S33D/S34D) was
inactive despite secreting normally (Figures S6B and S6C, the
bottom panel).
Tiki Cleavage of Multiple Wnt Proteins
Tiki1/2 inhibits Xwnt8 in embryos (Figures 1 and S3D and data
not shown). TIKI2 cleaved Xwnt8, as shown by removal of the
amino-terminal HA tag (after the signal peptide) from HA-
Xwnt8-FLAG, which also had a carboxy-terminal FLAG tag (Fig-
ure 5J). MS analyses of Xwnt8-Myc or HA-Xwnt8-FLAG cleaved
by TIKI2 suggested identically two amino-terminal cleavage
sites, resulting in removal of 17 and 20 residues of mature
Xwnt8, respectively (Figure 5C and data not shown). TIKI2 also
cleaved HA-Wnt5a at the amino terminus (Figure 5K). The low
amount of Wnt5a production has hindered identification of the
cleavage site(s). TIKI2 did not cleave HA-Xwnt11-FLAG (Fig-
ure 5L), implying Wnt specificity.
Amino-terminal residues are highly variable among Wnt
proteins despite conservation among paralogs in vertebrates.
Consequently, TIKI2 cleavage sites in Wnt3a and Xwnt8 do
not reveal recognizable consensus motifs (Figure 5C). To
glimpse into this apparent paradox, we found that TIKI2, but
not KRM2 (Kremen2; Mao et al., 2002), bound to Wnt3a,
Xwnt8, and Wnt5a but not Rspo1 (Figures S6D–S6F and data
not shown). This was not unanticipated given that enzyme-
substrate pairs often show interaction. Intriguingly, TIKI2, but
not KRM2, also bound to Xwnt11 (Figure S6G). We speculate
that TIKI may interact with conserved motifs within Wnt(C) Amino-terminal cleavage of Wnt3a and Xwnt8 by TIKI2. The big and small arro
Wnt3aDN was engineered to be identical to TIKI-cleaved Wnt3a.
(D) TIKI cleaved the HA tag from HA-Wnt3a. TIKI1 cDNA was transfected at a 10
(E) TIKI did not cleave Rspo1. *nonspecific.
(F) Endogenous TIKI2 cleaved Wnt3a in HEK293T cells. TIKI2 siRNAs were as in
(G) Wnt3a(S25D/L26D) and Wnt3a(S25D/L26D/S33D/S34D) were partially and f
mutants exhibited slower mobility.
(H) Wnt3aDN was inactive as examined by cDNA transfection in 2-fold dilutions.
(I) Wnt3aDN in CM partitioned in the aqueous phase.
(J–L) TIKI2 cleaved the HA tag from HA-Xwnt8-FLAG and HA-Wnt5a but not
monitored.
(M) HA-Wnt3a was cleaved by TIKI2N, but not by KRM2N or TIKI2ND (FLAG-tag
(N) Silver staining of purified KRM2N, TIKI2N, or TIKI2ND.
(O) Purified TIKI2N, but neither KRM2N nor TIKI2ND, cleaved recombinant HA-W
(P) TIKI2N cleavage of HA-Wnt3a was inhibited by 1, 10-Phenanthroline but not B
than manufacturer’s recommended doses.
(Q) TIKI2N cleavage of HA-Wnt3a was enhanced by Co2+ or Mn2+ but inhibited b
(R) TIKI2N inhibition by 1, 10-Phenanthroline was rescued by Co2+ or Mn2+ (lane
See also Figures S4, S5, S6, and S7 and Table S4.proteins, thereby orientating itself for cleaving a specific Wnt
amino terminus.
Tiki Is Probably a Metalloprotease
TIKI2N was sufficient for Wnt3a inhibition and cleavage in cells
(Figures 5, S2C, and S4). We purified via a tandem affinity proce-
dure recombinant TIKI2N, which upon in vitro incubation with
purified HA-Wnt3a triggered Wnt3a cleavage and the HA disap-
pearance (Figures 5N and 5O). KRM2N, which corresponds to
the Kremen2 ectodomain, or TIKI2ND, a deletion mutant that
lacks a TIKI-domain segment and neither modifies Wnt3a nor
inhibits Wnt signaling in cells (Figures 5M and S6H), did not
cleave HA-Wnt3a in vitro (Figure 5O). MS analyses of recombi-
nant WNT3A cleaved by TIKI2N in vitro indicated cleavage at
identical (major and minor) amino-terminal sites as observed in
cells (data not shown). These results suggest that Tiki is, or is
associated with, a Wnt protease.
We characterized TIKI protease activity in vitro. TIKI2N
cleavage of HA-Wnt3a became obvious at 2 hr and exhibited
preference for neutral to slightly basic pH (pH 7–9) (Figures
S7A and S7B). We applied protease inhibitors to survey which
protease family TIKI belongs to. TIKI2N was sensitive neither
to Bestatin, an aminopeptidase inhibitor, nor to a mixture of
inhibitors for serine, cysteine, and aspartic proteases and
aminopeptidases (Figures 5P, S7C, and S7D). Remarkably,
TIKI2N was inhibited by a metalloprotease inhibitor, 1,10-
phenanthroline, which is a divalent metal chelator and was
applied at concentrations 100-fold lower than recommended
doses (Figure 5P). TIKI2N was also inhibited, albeit mildly, by
EDTA, another metalloprotease inhibitor and divalent metal
chelator (Figure S7E) (Barrett et al., 1998; Overall and Blobel,
2007). Metalloproteases are defined by their dependence on
divalent metals as cofactors. TIKI2N cleavage of HA-Wnt3a
in vitro was enhanced by Co2+ or Mn2+ (Figure 5Q, lanes 4
and 12) but not by Ni2+, Cu2+, or Zn2+, which in fact inhibited
TIKI2N (Figure 5Q, lanes 6, 8, and 10). Importantly, Co2+ or
Mn2+ restored TIKI2N enzymatic activity that was inhibited by
1,10-phenanthroline (Figure 5R, lanes 6 and 8). Thus, Tiki is
probably a Co2+- or Mn2+-dependent metalloprotease.wheads indicate major and minor cleavage sites, respectively (see Figure S5).
-fold higher dose than that of TIKI2 for similar protein levels.
Figures 4B and 4C.
ully resistant to TIKI2N cleavage, respectively (lanes 4 and 6 versus 2). Both
Error bars represent SD in triplicates.
HA-Xwnt11-FLAG. Levels of KRM2N and TIKI2N (both FLAG-tagged) were
ged), in HEK293T cells.
nt3a in vitro.
estatin. Sixteen micromoles of 1, 10-Phenanthroline is about 100 times lower
y Ni2+, Cu2+, or Zn2+.
s 6 and 8).
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Figure 6. Wnt3a Oxidation-Oligomerization due to Tiki Cleavage
(A–D) Secreted Wnt3a in CM. The arrow and * indicate Wnt3a monomers and oligomers in nonreducing gels, respectively (top). Note the enormous size of the
upper * band. Reducing gels (bottom) were also shown.
(A) Wnt3a from TIKI2-expressing cells formed oxidized oligomers exclusively.
(B) Wnt3aDN formed oxidized oligomers.
(C) Oxidized Wnt3a oligomers partitioned exclusively in the aqueous phase, whereas Wnt3a monomers partitioned in detergent.
(D) Wnt3a(C77A) formed oxidized oligomers regardless of TIKI2. This experiment was performed together with the one presented in (A), and a common control
lane was used. Secreted Wnt3a(C77A) after TIKI2 cleavage migrated slower in the reducing gel due to altered N-glycosylation (see Figure S4E).
(E)Wnt3a,Wnt3a(C77A), andWnt3a(S209A) behaved similarly in whole-cell lysates. Each existed asmonomers (arrow) and heterogeneous oxidized species from
dimers (arrowhead) to larger oligomers (*), regardless of TIKI2 cleavage.
See also Figures S6 and S7.Wnt Oxidation-Oligomerization Induced by Tiki
Cleavage
Tiki-induced elimination of Wnt3a hydrophobicity (Figures 5A
and S4C) was puzzling but intriguing. We unexpectedly found
that Tiki-modified Wnt3a, but not control Wnt3a, existed in CM
as large (>400 kDa) soluble oligomers, which were linked by
intermolecular disulfide bonds and were massive in size, as
a significant fraction showedminimal migration in gel (Figure 6A).
This oxidized Wnt oligomerization was secondary to Tiki
cleavage, as Wnt3aDN formed, without Tiki expression, similar1572 Cell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc.large soluble oligomers that could be reduced (Figure 6B), as
did Wnt3a(S25D/L26D/S33D/S34D), which is also inactive (Fig-
ure S6C). Interestingly, oxidized Wnt3a oligomers partitioned
exclusively aqueously, whereas monomeric (or noncovalently
oligomeric) Wnt3a partitioned in detergent (Figure 6C), implying
that lipid adducts may have been buried inside Wnt oligomers.
Control Wnt3a exhibited traces of oxidized oligomers (Figures
6A–6C), which contained intact Wnt3a as demonstrated by the
amino-terminal HA tag (Figure S7F). Thus Wnt3a may have
intrinsic oxidation-oligomerization propensity, which the Wnt3a
amino terminus acts to minimize. However, we cannot rule out
that the trace amount of oxidized oligomers of control Wnt3a
may be due to overexpression.
Tiki-modifiedWnt3a, Wnt3aDN, andWnt3a(C77A) bare strong
similarity in hydrophilic behavior and inactivity. Remarkably,
Wnt3a(C77A) also formed oxidized oligomers in CM regardless
of Tiki expression (Figure 6D). Although it is unknown whether
these various oxidized Wnt3a oligomers were formed via
disulfide bonds among the same cysteines, Wnt3a C77 palmi-
toylation may also be required for minimizing Wnt3a oxidation-
oligomerization, a role shared by the Wnt3a amino terminus
that is removable by Tiki. However, whereas Tiki-modified
Wnt3a and Wnt3aDN are severely impaired in autocrine
and paracrine signaling (Figures 4J, 5H, S2B, and S2C),
Wnt3a(C77A) retains residual autocrine signaling activity (Fig-
ure S4G) (Willert et al., 2003), implying quantitative or qualitative
differences in roles that the Wnt3a amino terminus and C77
palmitoylation play in maintaining Wnt3a activity.
We examined where Wnt oligomers were formed during
biogenesis. Surprisingly, in whole-cell lysates, there was little
difference among Wnt3a, Wnt3a(C77A), and Wnt3a(S209A),
regardless of TIKI2 cleavage: each existed as monomers (or
noncovalent oligomers) and heterogeneous oxidized oligomers
from likely dimers to larger multimers (Figure 6E). These results
may be consistent with our suspicion that during biogenesis,
Wnt3a has intrinsic oxidizing propensity, which is minimized by
the Wnt3a amino terminus and C77 palmitoylation during/after
secretion, leaving only traces of oxidized oligomers in CM. But
for TIKI-cleaved Wnt3a or Wnt3a(C77A), this propensity may
be exacerbated during/after secretion, resulting in massive
oxidized oligomers in CM. Wnt3a(S209A) was not secreted as
reported (Figure S7G) (Takada et al., 2006).
Tiki Can Act in Both Wnt-Producing
and Wnt-Responding Cells
Cellular localization (Figures 4E–4G) suggests that Tiki may act
on secretory and plasma membranes. Consistent with both
scenarios, Tiki1N (Figure S2C) and Tiki1N-KDEL, which harbors
the ER-retention KDEL sequence at the Tiki1N carboxyl terminus
and was hardly secreted (Figure S7H), each potently inhibited
Wnt signaling (Figure S6H). Tiki showed inhibition in Wnt-
producing cells but apparently not in Wnt-responding cells
(Figure 4H). We were concerned, however, that excessive
Wnt3a added acutely might have activated signaling prior to,
or overwhelmed, Tiki function. We thus investigated this issue
under more physiological settings in embryos. We performed
Wnt-responsive reporter assays via Tiki overexpression or
knockdown. First, we injected two animal blastomeres sepa-
rately with Xwnt8 mRNA or S01234-luciferase DNA (Figure 7A),
which is driven by the promoter of the Siamois gene, a direct
Wnt target (Brannon et al., 1997). Animal blastomeres were
chosen as their progenies do not express Tiki1 (Figure 2).
Xwnt8 induced expression of the reporter (Figure 7A) but not of
S0-luciferase in which TCF-binding sites were mutated (Brannon
et al., 1997) (data not shown). Coinjection of Xwnt8 with Tiki1,
but not LDLR, inhibited the reporter (Figure 7A). Thus Tiki1 could
inhibit Wnt activity in Wnt-producing cells as seen in mammalian
cells. We then altered the coinjection scheme by injectingXwnt8 in one blastomere and injecting Tiki1 (or LDLR) mRNA
plus S01234-luciferase in a neighboring blastomere (Figure 7B).
Tiki1, but not LDLR, inhibited Xwnt8-induced reporter in Wnt-
responding cells (Figure 7B).
We addressed the same question complementarily via
Tiki1MO knockdown in dorsal blastomeres whose progenies
express Tiki1 endogenously. We coinjected an Xwnt8 plasmid
(transcribing Xwnt8 after mid-blastula transition) plus Tiki1MO
or control MO into a blastomere (i.e., to knock down Tiki1 in
Xwnt8-producing cells) and injected S01234-luciferase into the
neighboring blastomere (Figure 7C). Alternatively, we injected
the Xwnt8 plasmid into a single blastomere and coinjected
S01234-luciferase plus Tiki1MO or control MO into the neigh-
boring blastomere (i.e., to knock down Tiki1 in Xwnt8-respond-
ing cells; Figure 7D). Xwnt8 induced S01234-luciferase, but
not S0-luciferase, and the Xwnt8 response was enhanced by
Tiki1MO under either condition (Figures 7C and 7D), Thus the
endogenous Organizer Tiki1 acts in both Wnt-producing and
Wnt-responding cells.
We further monitored how Tiki1 inhibits Wnt-induced nuclear
b-catenin accumulation. We injected Xwnt8 plus red fluorescent
protein (RFP) mRNA into an animal blastomere and injected
Tiki1 or LDLR mRNA plus fluorescein dextran (FLD) into a neigh-
boring blastomere (Figure 7E). Thus, Xwnt8-expressing cells
were RFP+ (red), whereas Wnt-responding cells that expressed
Tiki1 or LDLR were FLD+ (green), and naive cells from uninjected
blastomeres lacked either fluorescence (Figures 7G, 7H, 7K, and
7L). Nuclear b-catenin (blue) was observed at stage 9 in Xwnt8-
expressing cells (red) due to autocrine signaling (arrows, Fig-
ure 7I) and in cells that expressed LDLR (green) in response to
Xwnt8 (arrowheads, Figure 7I). By contrast, much fewer Tiki1-
expressing cells (green, Figure 7K) exhibited nuclear b-catenin
(arrowheads, Figure 7M). Quantification showed 75% of LDLR-
expressing and naive cells versus 30% of Tiki1-expressing
cells displaying nuclear b-catenin (Figure 7F), supporting that
Tiki1 functions in Wnt-responding cells. We propose that Tiki
functions in Wnt-producing cells by acting in the secretory
pathway and at the plasma membrane and in Wnt-responding
cells by acting at the plasma membrane.
DISCUSSION
We identified a family of Tiki proteins that inactivate Wnt mor-
phogens through proteolytic cleavage. Tiki1 is expressed in the
Spemann-Mangold Organizer and is required for head formation
in Xenopus embryos. In the absence of Tiki1, expression of
all head organizer genes examined is diminished, resulting in
defective head organizer function, which in turn causes defi-
ciency in anterior-neural patterning. Tiki1 appears to be required
for Organizer maintenance, which is antagonized by zygotic Wnt
signaling, but not for initiation of Organizer formation, which
requires maternal Wnt signaling. Tiki1 as a founding ‘‘Wnt
inactivator’’ thus joins known Organizer-specific Wnt antago-
nists such as Dkk1 and Frzb/sFRP3 and acts to ensure
a ‘‘Wnt-free’’ zone for anteriorization. Tiki1 functions in both
Wnt-producing and Wnt-responding cells, thereby inactivating
Wnt proteins made by the Organizer or by neighboring or poste-
rior regions. Organizer Tiki1 expression is induced by maternalCell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc. 1573
Figure 7. Tiki1 Functions in Both Wnt-Producing and Wnt-Responding Cells
(A) Tiki1 acts in Xwnt8-producing cells. Tiki1mRNA (100 pg) coinjected with Xwnt8mRNA (20 pg) inhibited Xwnt8-induced S01234-luciferase in neighboring cells.
LDLR: a control.
(B) Tiki1 acts in Xwnt8-responding cells. Tiki1 mRNA coinjected with S01234-luciferase inhibited the reporter induced by Xwnt8 from neighboring cells that
received Xwnt8 mRNA.
(C) The endogenous Tiki1 acts in Wnt-producing cells. Tiki1MO (20 ng) coinjected with CS2+Xwnt8 DNA (40 pg) in a single dorsal blastomere enhanced Xwnt8-
induced S01234-luciferase in neighboring cells. ConMO: control MO.
(D) The endogenous Tiki1 acts in Wnt-responding cells. Tiki1MO coinjected with S01234-luciferase enhanced the reporter induced by Xwnt8 from neighboring
cells that received CS2+Xwnt8 DNA.
(E–N) Tiki1 reduces nuclear b-catenin levels by acting in Wnt-responding cells. Tiki1 or LDLR mRNA (200 pg) (FLD+, green) and Xwnt8 mRNA (20 pg) (RFP+, red)
were injected into neighboring blastomeres. Stage 9 animal cap cells were imaged with an anti-b-catenin antibody (blue). Examples of Xwnt8-expressing cells
(arrows) and Tiki1- or LDLR-expressing cells (arrowheads) are highlighted. Only cells within the distance of five cell bodies from Xwnt8-expressing cells were
counted. No nuclear b-catenin-positive cells were found in areas free of Xwnt8-expressing cells (not shown). All cells were positive for plasma membrane-
associated b-catenin. Statistical data were derived from three independent experiments (F). **p < 0.001.
All error bars represent SD in triplicates. See also Figures S7.Wnt signaling, reflecting a negative feedback loop that is
common inmorphogen signaling. Tiki-mediatedWnt inactivation
may exist before the split of invertebrate and vertebrate lineages,1574 Cell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc.as a Tiki homolog is encoded in the genome of sponge
Amphimedon and of sea anemone Nematostella. Tiki proteins
share homology with putative bacterial gumN proteins of
unknown functions and thus represent an initial example of Wnt
components with a prokaryotic origin and further imply potential
mechanisms for gumN and related TraB proteins.
Tiki is likely, or is associated with, a divalent metal (Co2+ or
Mn2+)-dependent metalloprotease that cleaves the amino
terminus of Wnt proteins, despite baring no recognizable
homology to known proteases. TIKI2 cleaves Wnt3a, Xwnt8,
and Wnt5a but not Xwnt11, implying broad yet stringent Wnt
specificity. Wnt amino-terminal residues are conserved among
vertebrate paralogs but are highly variable among nonparalogs,
as such TIKI2 cleavage sites in Wnt3a and Xwnt8 do not reveal
a recognizable consensus. As TIKI2 interacts with each tested
Wnt including Xwnt11, TIKI may bind to a conserved motif
within Wnt proteins and then cleave Wnt amino termini selec-
tively. Tiki neither inhibits signaling by Nodal/TGF-b or bFGF
nor cleaves Rspo1. Importantly, TIKI fails to cleave a Wnt3a
mutant with missense alterations at the proteolytic sites, further
reflecting selectivity for peptide bond hydrolysis.
Tiki cleavage results in Wnt3a oxidation and oligomerization
through inter-Wnt disulfide bond formation. These soluble
Wnt3a oligomers exhibit drastically altered biophysical and bio-
chemical properties including the loss of hydrophobicity and
of receptor binding, which are fully recapitulated by Wnt3aDN.
Thus the Wnt amino terminus has a critical role in preventing
Wnt oxidation-oligomerization, a feature exploited by Tiki1
during anterior patterning. This feature may also relate to Wnt
lipid modifications, which are exemplified by Wnt3a C77 palmi-
toylation and S209 acylation and have distinct roles in Wnt
biogenesis/function. S209 acylation is essential for Wnt3a
secretion (Takada et al., 2006) due to its involvement in Wnt3a
binding to the Wntless transporter (Ba¨nziger et al., 2006;
Coombs et al., 2010). Wnt3a C77 palmitoylation is suggested
to be required for activity but not secretion (Willert et al., 2003)
via an as-yet unclear mechanism. Our study suggests a potential
link between C77 and/or its palmitoylation and Wnt folding.
Wnt3a(C77A), which lacks palmitoylation and is commonly
used in Wnt studies, shows behaviors similar to those of Tiki-
modified Wnt3a/Wnt3aDN, as they are all hydrophilic and inac-
tive and form in CM oxidized oligomers, which in fact may
explain why each fails to bind to Fz or LRP6. We do not discount
that C77 palmitoylation and the Wnt3a amino terminus may be
involved in binding to both Fz and LRP6 simultaneously, but
such a scenario appears to be more convoluted. Therefore,
C77 palmitoylation, like the Wnt3a amino terminus, is likely
required for keeping Wnt3a from oxidation-oligomerization
during biogenesis. A recent study shows that a mutant
DrosophilaWingless (Wg) protein, WgC93A, which has an alanine
substitution at C93 (equivalent to Wnt3a C77), is secreted but
forms large-sized (>1.3M Dalton) soluble aggregates (Mulligan
et al., 2012). Although it is to be determined whether WgC93A
aggregates are formed by inter-Wg disulfide bonds like
Wnt3a(C77A) oligomers, a conserved role of palmitoylation in
preventing oligomerization may be shared between Wg and
Wnt3a. We caution, however, that Wnt3a(C77A) or WgC93A is
only a surrogate for, but not identical to, Wnt3a or Wg lacking
palmitoylation. We note that although oxidized Wnt3a oligomers
are inactive, our findings do not exclude the possibility that
active Wnt3a proteins are noncovalent oligomers or monomers.Oxidized oligomers formed by Tiki-modified Wnt3a or
Wnt3a(C77A), which harbors dual lipids or a single lipid, are
soluble aqueously (Willert et al., 2003; this study) and in fact
exhibit strict correlation with hydrophilic behavior, in sharp
contrast to Wnt3a monomers. Thus, these inactive Wnt oligo-
mers are unlikely to be misfolded/denatured aggregates but
rather may represent an alternative conformation that buries
the lipid(s) inside, thereby exhibiting hydrophilic behaviors. It is
intriguing how Tiki removal of eight amino-terminal residues,
which do not contain a cysteine, exacerbates inter-Wnt3a
oxidation, which seems to be prevalent during biogenesis
(Figure 6E). Among important questions are the specificity and
mechanismof Tiki1/2 towardWnt proteins,whether Tiki cleavage
regulates noncanonical Wnt pathways, how the Wnt amino
terminus and palmitoylation maintain Wnt in the active state,
and whether oxidized Wnt oligomers, given the reversible nature
of oxidation, canbe reduced/functionally reactivatedby reducing
enzymes or disulfide isomerases. Our study of Wnt cleavage
by Tiki has uncovered an additional dimension of Wnt regula-
tion that depends on unsuspected but critical Wnt biogenic
properties. As Wnt signaling plays essential roles in diseases
including cancer and osteoporosis, TIKI1/2 as likely Wnt-proteo-
lytic enzymes may represent potential therapeutic targets.
EXPERIMENTAL PROCEDURES
Xenopus Embryo Manipulations and cDNA Library Screening
Procedures for embryo manipulation, reverse transcription PCR, and in situ
hybridization were performed as previously described (Tamai et al., 2000).
The Arrayed Xenopus tropicalis full-length cDNAs (Voigt et al., 2005) were
used for the screening as performed previously (Kato et al., 2002). cDNA pools
(in the CS107 vector) that contain 96 independent clones were transcribed
in vitro using SP6 polymerase, and the resulting mRNA pools were injected
into the dorsal side of the embryo at 4-cell stage at the dose of 10 ng
RNA/embryo. Injected embryos were scored at stages 30–31 for enlarged or
diminished anterior development. The positive pools were divided into smaller
pools, and the same process was repeated till a single cDNA was identified.
Morpholino Injection
To examine Tiki1MO specificity, 500 pg Tiki1-FLAG (targeted by MO) or
HA*Tiki1 (resistant to MO) were injected with or without the Tiki1MO (5, 10,
20, 40 ng) into the animal pole at the 2-cell stage, and animal caps were
dissected at stage 10 for western blotting. To knockdown the endogenous
Tiki1, 20 ng of control MO, Tiki1MO, or Tiki1MO together with 50 pg of
HA*Tiki1 mRNA were injected into two dorsal blastomeres at the 8-cell stage,
and the phenotype was scored at stage 42.
Cell Culture, Transfection, and Reporter Assay
HEK293T, HeLa, L, and L-Wnt3a cells (fromATCC) weremaintained in Dulbec-
co’s modified Eagle’s medium (DMEM; Invitrogen) supplemented with 10%
fetal bovine serum (FBS) and 1% penicillin-streptomycin-glutamine (Invitro-
gen). Lipofectamine 2000 (Invitrogen) or Fugene6 (Roche) was used for all
cell transfections. L and L-Wnt3a cells that stably express TIKI2 were gener-
ated by infecting cells with retroviruses and selected by puromycin. L cells
stably expressing Wnt3a(FLAG) were established by transfecting L cells with
a Wnt3a(FLAG)-expressing vector and selected with neomycine. L cells stably
expressing both Wnt3a(FLAG) and TIKI2 were also generated. TOPFLASH
reporter assay was performed as previously described (MacDonald et al.,
2008).
RNAi
To knockdown human TIKI2 in the TOPFLASH reporter assay, HEK293T cells
in 24-well plates were transfected with 100 ng of TOPFLASH reporter, 5 ng ofCell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc. 1575
TK-Renilla reporter, 5 ng of empty vector or Wnt3a, and 20 nM of each siRNA.
The reporter activities were examined 48 hr post-transfection. To examine the
cleavage ofWnt3a by endogenous TIKI2, 150 ng of HA-Wnt3a was transfected
together with 20 nM of each siRNA into HEK293T cells in a 12-well plate, and
after 48 hr, the resulting CM were analyzed by western blotting with anti-HA
and anti-Wnt3a antibodies.
In Vitro Treatment of Wnt3a with Purified Proteins
About 50 ng purified TIKI2N, KRM2N, or TIKI2ND protein wasmixed with 10 ng
purified HA-Wnt3a in a total volume of 10 ml HEPES buffer (50 mM HEPES
[pH 7.4], 100 mM NaCl, 0.2% NP-40) and incubated at 30C for 12 hr. To
examine TIKI2N activity in different pH conditions, the following buffer was
used instead of HEPES, 100 mM sodium acetate (pH 5.5), 100 mM Tris-HCl
(pH 6, 7, 8, 9), or 50 mM CAPS (pH 10, 11), and the reaction was incubated
for 4 hr. To examine the effect of inhibitors on TIKI2N activity, the inhibitors
(dissolved in DMSO) were added in the reaction system for 4 hr, and DMSO
was used as a negative control. To examine the effect of divalent metals,
50 mM of each divalent metal ion was applied in the in vitro reaction and
incubated for 2 hr. To rescue TIKI2N activity with divalentmetals after inhibition
with 1, 10-Phenanthroline, 20 mM of 1, 10-Phenanthroline was first applied in
the in vitro reaction for 1 hr, and 50 mM of each metal ion was added and
incubated for another 2 hr. The reaction product was analyzed by SDS-
PAGE and western blotting with anti-HA and anti-Wnt3a antibodies. For MS
analysis, 200 ng of recombinant WNT3A (from Stem RD) was incubated
with about 500 ng of TIKIN or KRM2N overnight at 30C and separated by
SDS-PAGE. The WNT3A bands were cut, trypsin digested, and subjected to
MS analyses.
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While this paper was in press, we became aware of a publication describing
the Xwnt8-mFz8CRD cocrystal structure (Janda et al., Science, published
online May 31, 2012. 10.1126/science.1222879), in which Xwnt8 C55 (equiv-
alent to Wnt3a C77) is involved in an intramolecular disulfide bond with
another cysteine. We note that the Wnt3a(C77A) data in our paper are
consistent with the possibility that Wnt3a C77 is analogously involved in
intra-Wnt3a disulfide bond formation, whose disruption in Wnt3a(C77A)
would result in an unpaired cysteine, potentially accounting for exacerbating
inter-Wnt3a oxidation and oligomerization as we observed.Cell 149, 1565–1577, June 22, 2012 ª2012 Elsevier Inc. 1577
